These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18704013)

  • 1. Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis.
    Figueiredo Costa S
    Shock; 2008 Oct; 30 Suppl 1():23-9. PubMed ID: 18704013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
    Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
    Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
    Septimus EJ; Kuper KM
    Clin Pharmacol Ther; 2009 Sep; 86(3):336-9. PubMed ID: 19571803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing antimicrobial therapy in sepsis and septic shock.
    Kumar A
    Crit Care Nurs Clin North Am; 2011 Mar; 23(1):79-97. PubMed ID: 21316569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of antimicrobial resistance on health and economic outcomes.
    Cosgrove SE; Carmeli Y
    Clin Infect Dis; 2003 Jun; 36(11):1433-7. PubMed ID: 12766839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial management of sepsis and septic shock.
    Sharma S; Kumar A
    Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A strategy and procedure for the antibacterial therapy of abdominal sepsis].
    Gel'fand BR; Gologorskiĭ VA; Ge'lfand EB; Alekseeva EA; Briukhov AN
    Anesteziol Reanimatol; 1998; (4):16-9. PubMed ID: 9770811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antimicrobial agents for use in the intensive care unit.
    Ritchie DJ; Alexander BT; Finnegan PM
    Infect Dis Clin North Am; 2009 Sep; 23(3):665-81. PubMed ID: 19665089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal antimicrobial therapy for sepsis.
    Fish DN
    Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S13-9. PubMed ID: 11885408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
    Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
    Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis and septic shock: selection of empiric antimicrobial therapy.
    Cunha BA
    Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
    Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
    Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis.
    Lehmann LE; Alvarez J; Hunfeld KP; Goglio A; Kost GJ; Louie RF; Raglio A; Regueiro BJ; Wissing H; Stüber F
    Crit Care Med; 2009 Dec; 37(12):3085-90. PubMed ID: 19633541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of antimicrobial therapy: what should we be using?
    Southwood LL
    Vet Clin North Am Equine Pract; 2006 Aug; 22(2):279-96, vii. PubMed ID: 16882476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department antimicrobial considerations in severe sepsis.
    Green RS; Gorman SK
    Emerg Med Clin North Am; 2014 Nov; 32(4):835-49. PubMed ID: 25441038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking the microbes in sepsis: advancements in treatment bring challenges for microbial epidemiology.
    Llewelyn MJ; Cohen J
    Clin Infect Dis; 2007 May; 44(10):1343-8. PubMed ID: 17443473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preface: optimizing antimicrobial therapy of sepsis and septic shock.
    Kumar A
    Crit Care Clin; 2011 Jan; 27(1):xi-xii. PubMed ID: 21144982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.